Faeth Therapeutics, Inc. (FTH) Current Reports & Earnings Releases
Upcoming
- 2026-11-13 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-23 | 8-K | Officer / Director Changes | SEC |
| 2026-06-18 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-15 | 8-K | Termination of Agreement, Officer / Director Changes, Charter Amendments, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-10 | 8-K | Officer / Director Changes, Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-22 | 8-K | Other Events | SEC |
| 2026-05-21 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-15 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-16 | 8-K | Officer / Director Changes | SEC |
| 2026-03-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-18 | 8-K | Material Agreement, Acquisition or Disposition, Unregistered Sales, Officer / Director Changes, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-13 | 8-K | Officer / Director Changes | SEC |
| 2025-12-23 | 8-K | Officer / Director Changes | SEC |
| 2025-11-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-30 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-10-17 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-07-09 | 8-K | Listing Notice | SEC |
| 2025-06-13 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-05-23 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-28 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-27 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-01-07 | 8-K | Listing Notice, Financial Statements & Exhibits | SEC |
| 2024-11-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-30 | 8-K | Officer / Director Changes | SEC |
| 2024-09-20 | 8-K | Officer / Director Changes | SEC |
| 2024-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-07-12 | 8-K | Listing Notice | SEC |
| 2024-06-27 | 8-K | Officer / Director Changes | SEC |
| 2024-06-13 | 8-K | Shareholder Vote Results | SEC |
| 2024-06-03 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-23 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-09 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-12 | 8-K | Officer / Director Changes | SEC |
| 2024-04-02 | 8-K | Officer / Director Changes | SEC |
| 2024-03-05 | 8-K | Material Agreement, Item 3.03, Financial Statements & Exhibits | SEC |
| 2024-02-28 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-08 | 8-K | Officer / Director Changes, Other Events | SEC |
| 2024-01-04 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.